AMRX
Price
$8.18
Change
-$0.05 (-0.61%)
Updated
Apr 2, 04:59 PM (EDT)
Capitalization
1.87B
29 days until earnings call
PRGO
Price
$27.91
Change
+$0.21 (+0.76%)
Updated
Apr 2, 04:59 PM (EDT)
Capitalization
4.35B
40 days until earnings call
Ad is loading...

AMRX vs PRGO

Header iconAMRX vs PRGO Comparison
Open Charts AMRX vs PRGOBanner chart's image
Amneal Pharmaceuticals
Price$8.18
Change-$0.05 (-0.61%)
Volume$30.53K
Capitalization1.87B
Perrigo
Price$27.91
Change+$0.21 (+0.76%)
Volume$12.24K
Capitalization4.35B
AMRX vs PRGO Comparison Chart
Loading...
AMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMRX vs. PRGO commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMRX is a Hold and PRGO is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (AMRX: $8.23 vs. PRGO: $27.70)
Brand notoriety: AMRX and PRGO are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AMRX: 120% vs. PRGO: 73%
Market capitalization -- AMRX: $1.87B vs. PRGO: $4.35B
AMRX [@Pharmaceuticals: Other] is valued at $1.87B. PRGO’s [@Pharmaceuticals: Other] market capitalization is $4.35B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.65B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMRX’s FA Score shows that 1 FA rating(s) are green whilePRGO’s FA Score has 1 green FA rating(s).

  • AMRX’s FA Score: 1 green, 4 red.
  • PRGO’s FA Score: 1 green, 4 red.
According to our system of comparison, AMRX is a better buy in the long-term than PRGO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMRX’s TA Score shows that 4 TA indicator(s) are bullish while PRGO’s TA Score has 4 bullish TA indicator(s).

  • AMRX’s TA Score: 4 bullish, 5 bearish.
  • PRGO’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, AMRX is a better buy in the short-term than PRGO.

Price Growth

AMRX (@Pharmaceuticals: Other) experienced а -3.52% price change this week, while PRGO (@Pharmaceuticals: Other) price change was +1.84% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.45%. For the same industry, the average monthly price growth was -0.08%, and the average quarterly price growth was -9.41%.

Reported Earning Dates

AMRX is expected to report earnings on May 02, 2025.

PRGO is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-1.45% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRGO($4.35B) has a higher market cap than AMRX($1.87B). PRGO has higher P/E ratio than AMRX: PRGO (341.25) vs AMRX (90.00). PRGO YTD gains are higher at: 8.841 vs. AMRX (3.914). PRGO has higher annual earnings (EBITDA): 525M vs. AMRX (400M). PRGO has more cash in the bank: 751M vs. AMRX (91.5M). AMRX has less debt than PRGO: AMRX (2.75B) vs PRGO (4.07B). PRGO has higher revenues than AMRX: PRGO (4.66B) vs AMRX (2.39B).
AMRXPRGOAMRX / PRGO
Capitalization1.87B4.35B43%
EBITDA400M525M76%
Gain YTD3.9148.84144%
P/E Ratio90.00341.2526%
Revenue2.39B4.66B51%
Total Cash91.5M751M12%
Total Debt2.75B4.07B68%
FUNDAMENTALS RATINGS
AMRX vs PRGO: Fundamental Ratings
AMRX
PRGO
OUTLOOK RATING
1..100
7715
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
69
Overvalued
PROFIT vs RISK RATING
1..100
43100
SMR RATING
1..100
9992
PRICE GROWTH RATING
1..100
4849
P/E GROWTH RATING
1..100
222
SEASONALITY SCORE
1..100
7550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PRGO's Valuation (69) in the Pharmaceuticals Other industry is in the same range as AMRX (95) in the Pharmaceuticals Major industry. This means that PRGO’s stock grew similarly to AMRX’s over the last 12 months.

AMRX's Profit vs Risk Rating (43) in the Pharmaceuticals Major industry is somewhat better than the same rating for PRGO (100) in the Pharmaceuticals Other industry. This means that AMRX’s stock grew somewhat faster than PRGO’s over the last 12 months.

PRGO's SMR Rating (92) in the Pharmaceuticals Other industry is in the same range as AMRX (99) in the Pharmaceuticals Major industry. This means that PRGO’s stock grew similarly to AMRX’s over the last 12 months.

AMRX's Price Growth Rating (48) in the Pharmaceuticals Major industry is in the same range as PRGO (49) in the Pharmaceuticals Other industry. This means that AMRX’s stock grew similarly to PRGO’s over the last 12 months.

PRGO's P/E Growth Rating (2) in the Pharmaceuticals Other industry is in the same range as AMRX (22) in the Pharmaceuticals Major industry. This means that PRGO’s stock grew similarly to AMRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMRXPRGO
RSI
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 2 days ago
66%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
66%
Momentum
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
73%
MACD
ODDS (%)
Bearish Trend 2 days ago
72%
Bearish Trend 2 days ago
61%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
75%
Bullish Trend 2 days ago
62%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
64%
Advances
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 6 days ago
63%
Declines
ODDS (%)
Bearish Trend 7 days ago
77%
Bearish Trend 2 days ago
66%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
62%
Bearish Trend 2 days ago
71%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Ad is loading...
AMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BBMC90.710.59
+0.65%
JPMorgan BetaBuilders US Mid Cap Eq ETF
CXSE34.200.16
+0.47%
WisdomTree China ex-State-Owd Entpr ETF
SHYL44.400.09
+0.20%
Xtrackers Short Duration High Yld Bd ETF
QVOY24.320.02
+0.08%
Q3 All-Season Active Rotation ETF
ETEC19.51N/A
N/A
iShares Breakthrough Envirtl Sol ETF

AMRX and

Correlation & Price change

A.I.dvisor tells us that AMRX and HROW have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AMRX and HROW's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMRX
1D Price
Change %
AMRX100%
-1.79%
HROW - AMRX
32%
Poorly correlated
-6.09%
CRON - AMRX
32%
Poorly correlated
-1.10%
EBS - AMRX
32%
Poorly correlated
-2.47%
ORGO - AMRX
30%
Poorly correlated
-0.93%
VRNOF - AMRX
30%
Poorly correlated
-1.51%
More